Filtered By:
Specialty: Dentistry
Condition: Diabetes
Drug: Pradaxa
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Dabigatran anticoagulation
Atrial fibrillation (AF) is a common heart arrhythmia for which anticoagulant agents such as warfarin are prescribed. A recently licensed anticoagulant, dabigatran (Pradaxa), diminishes the risk of stroke or systemic emboli in patients with AF and those having joint replacement surgery. Adult patients with non-valvular AF with previous stroke, transient ischemic attack or systemic embolism, left ventricular ejection fraction less than 40%, symptomatic heart failure exceeding New York Heart Association class 2, or age over 65 years with diabetes mellitus, coronary artery disease or hypertension are also candidates for dabigatran therapy.
Source: Dental Abstracts - May 1, 2015 Category: Dentistry Tags: Hands On Source Type: research
